- €6.19bn
- €17.49bn
- €7.52bn
Brief: Grifols Approves Reduction Of Up To 10% Of Its Share Capital
Brief: Grifols Launches Fibrinogen Concentrate For Acute Bleeding Episodes In The U.S.
Brief: Grifols' Egypt Unit Adds €180 Mln Of Additional Investment In Project
Spanish stocks - Factors to watch on June 12
Spanish stocks - Factors to watch on May 21
Press Digest: Canada - May 18
Grifols falls after Q1 miss, FX pressure
Spanish stocks - Factors to watch on May 8
Brief: Grifols On Track To Deliver 2026 Objectives
Brief: Grifols Q1 Adjusted EBITDA EUR 381 Million
Brief: Grifols Closes 29 Plasma Donation Centers In US To Optimise Operations
Spanish stocks - Factors to watch on April 23
Brief: Grifols Receives FDA Approval For Its Malaria Blood Screening Assay
Brief: Grifols Concludes Successful Refinancing Of 2027 Debt Maturities
Brief: Grifols Plans To Redeem 500 Mln Euro Of 7.5% 2030 Bonds To Further Optimize Its Capital Structure
Spanish stocks - Factors to watch on April 9
Spanish stocks - Factors to watch on April 2
Brief: Grifols Refinances All 2027 Maturities Following Upsized EUR 3 Bln Term Loan B
Spanish stocks - Factors to watch on March 27